Non-Invasive Prenatal Testing (NIPT) Market Forecast 2017-2021

Non-invasive prenatal testing (NIPT) has received importance in the recent past due to increasing awareness about genetic disorders and availability of accurate noninvasive tests. NIPT testing is non-invasive has no risk of miscarriage as compared to other tests such as chorionic villus sampling (CVS) or amniocentesis. Down syndrome is one of most commonly diagnosed using NIPT. Some of the key genetic disorders diagnosed using NIPT include Edward's syndrome, Patau syndrome and Down syndrome. Advancing maternal age has increased risk of genetic disorders among neonatal. Average age of first time mothers is increasing globally due to diversified culture and increasing number of working women. Centers for Disease Control and Prevention (CDC) also states that the risk for Down syndrome increases with age of mother, with sharp increase after 30 years of age. Greece, Australia, South Korea, Japan, Italy, Switzerland, Luxemburg, Singapore, Spain and Ireland are 10 leading countries with average pregnant women age 30 years and above. Hence prevalence of genetic disorders such as Down syndrome is expected to be high in these regions.

Request Free Report Sample@ http://www.sa-brc.com/Global-Non-Invasive-Prenatal-Testing-NIPT-Market-Assessment--Forecast-2017-2021/up109

Popularity of the test is high in the North American and Europe where there is increased awareness about genetic disorders and genetic tests. Hence these regions lead the global non-invasive prenatal testing market. With prior awareness about genetic disorders in fetus, family can plan medical treatment that may help patients with Down syndrome in living a productive life in the future. There are various families in the U.S. who are looking forward to adopt children with Down syndrome as a social service. National Down Syndrome Network is a leading organization in the U.S. assisting with adoptions. With prior diagnosis through NIPT, parents can make timely arrangements for adoption. Although NIPT provides accurate screening of certain genetic disorders, it is also observed that various mothers have found themselves under dilemma after NIPT screening tests. False positive tests are common and confirmation tests are usually recommended in case of positive NIPT screening. These tests have high risk of miscarriage, and not covered by major insurance providers. These factors may impede the growth of non-invasive prenatal testing market.

Some of the key brands available in the market include MaterniT21 PLUS, Bambni Test, Veracity, NIFTY, Panorama, informaSeq and various others. Increasing popularity has added new players to the market in the recent past. Considering more than 200 million pregnancies annually, there exists immense potential for NIPT market growth. Key players in the non-invasive prenatal testing market include Ariosa Diagnostics, Genesis Genetics, Natera, Inc., Sequenom Laboratories and BGI Diagnosis Co., Ltd.

Request For TOC@ http://www.sa-brc.com/Global-Non-Invasive-Prenatal-Testing-NIPT-Market-Assessment--Forecast-2017-2021/upcomingdetail109

NOTE: This report is currently under research and will be made available to clients on request.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
Office No. 14,
Hermes Kunj, Mangaldas Road,
Pune, 411001
India
Phone: +91-02041210872
Email: support@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.